Cargando…

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab

INTRODUCTION: A growing number of evidences suggest that the combination of hyperinflammation, dysregulated T and B cell response and cytokine storm play a major role in the immunopathogenesis of severe COVID-19. IL-6 is one of the main pro-inflammatory cytokines and its levels are increased during...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Biasi, Sara, Mattioli, Marco, Meschiari, Marianna, Lo Tartaro, Domenico, Paolini, Annamaria, Borella, Rebecca, Neroni, Anita, Fidanza, Lucia, Busani, Stefano, Girardis, Massimo, Coppi, Francesca, Mattioli, Anna Vittoria, Guaraldi, Giovanni, Mussini, Cristina, Cossarizza, Andrea, Gibellini, Lara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196248/ https://www.ncbi.nlm.nih.gov/pubmed/37215114 http://dx.doi.org/10.3389/fimmu.2023.1123807

Ejemplares similares

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
por: Gibellini, Lara, et al.
Publicado: (2022)

Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
por: Paolini, Annamaria, et al.
Publicado: (2022)

Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia
por: Lo Tartaro, Domenico, et al.
Publicado: (2022)

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
por: Lo Tartaro, Domenico, et al.
Publicado: (2023)

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
por: Gibellini, Lara, et al.
Publicado: (2020)

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
por: Cossarizza, Andrea, et al.
Publicado: (2023)

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
por: Paolini, Annamaria, et al.
Publicado: (2021)

Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
por: De Biasi, Sara, et al.
Publicado: (2020)

A Comprehensive Analysis of Cytokine Network in Centenarians
por: Pinti, Marcello, et al.
Publicado: (2023)

Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy
por: De Biasi, Sara, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria
por: Busani, Stefano, et al.
Publicado: (2020)

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
por: Riva, Giovanni, et al.
Publicado: (2021)

Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
por: Coloretti, Irene, et al.
Publicado: (2023)

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
por: Gibellini, Lara, et al.
Publicado: (2020)

T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy
por: Cossarizza, Andrea, et al.
Publicado: (2012)

Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
por: Busani, Stefano, et al.
Publicado: (2020)

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
por: Mussini, Cristina, et al.
Publicado: (2023)

Evidence for mitochondrial Lonp1 expression in the nucleus
por: Gibellini, Lara, et al.
Publicado: (2022)

Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022)

Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
por: Coloretti, Irene, et al.
Publicado: (2021)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
por: Mussini, Cristina, et al.
Publicado: (2021)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

Innate immunity changes in soccer players after whole-body cryotherapy
por: Selleri, Valentina, et al.
Publicado: (2022)

Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy
por: De Biasi, Sara, et al.
Publicado: (2021)

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019)

Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions
por: Gibellini, Lara, et al.
Publicado: (2023)

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
por: Busani, Stefano, et al.
Publicado: (2021)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Impaired Mitochondrial Morphology and Functionality in Lonp1(wt/−) Mice
por: De Gaetano, Anna, et al.
Publicado: (2020)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

COVID-19 pandemic: usefulness of telemedicine in management of arrhythmias in elderly people
por: Mattioli, Anna Vittoria, et al.
Publicado: (2020)

Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
por: Biagioni, Emanuela, et al.
Publicado: (2023)

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
por: Campani, Simone, et al.
Publicado: (2023)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology
por: Nasi, Milena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e94083nb2bet4ghs7ukh7jmqll